| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
CFO
1 company
Kies Peter is a CFO at INOVIO PHARMACEUTICALS, INC.. Recent SEC Form 4 filings include 0 buys and 10 sells.
Estimated insider holdings value: $44K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 9, 2021 | INO Inovio Pharmaceuticals, Inc. | CFO | Sale+OE | 33,750 | $10.01 | $337,837.50 | -20.5% | -14.8% | -83.5% | |
| Jun 3, 2021 | INO Inovio Pharmaceuticals, Inc. | CFO | Sell | 10,000 | $8.03 | $80,300.00 | -6.2% | +10.8% | -77.6% | |
| Apr 21, 2021 | INO Inovio Pharmaceuticals, Inc. | CFO | Sell | 10,000 | $8.52 | $85,200.00 | -5.9% | -6.2% | -68.7% | |
| Jan 15, 2021 | INO Inovio Pharmaceuticals, Inc. | CFO | Sale+OE | 30,000 | $10.02 | $300,558.00 | -20.1% | - | - | |
| Dec 15, 2020 | INO Inovio Pharmaceuticals, Inc. | CFO | Sale+OE | 20,000 | $10.69 | $213,706.00 | -14.4% | - | - | |
| Jul 15, 2020 | INO Inovio Pharmaceuticals, Inc. | CFO | Sale+OE | 35,000 | $24.95 | $873,208.00 | -22.7% | - | - | |
| Jun 30, 2020 | INO Inovio Pharmaceuticals, Inc. | CFO | Sell | 35,000 | $26.50 | $927,500.00 | -22.7% | - | - | |
| Nov 29, 2018 | INO Inovio Pharmaceuticals, Inc. | CFO | Sale+OE | 10,001 | $5.28 | $52,805.28 | -13.9% | - | - | |
| Jul 10, 2018 | INO Inovio Pharmaceuticals, Inc. | CFO | Sale+OE | 35,000 | $4.44 | $155,250.00 | -20.7% | - | - |